Healthcare -
Biotechnology - NASDAQ - US
$ 0.356
-49.1 %
$ 129 M
Market Cap
-0.48
P/E
LXRX - COST OF REVENUE
Cost of Revenue LXRX - Lexicon Pharmaceuticals, Inc.
85 K
LAST VALUE
-96.07%
2 YEAR CAGR
-49.11%
5 YEAR CAGR
-50.15%
10 YEAR CAGR